{
  "actions": [
    {
      "acted_at": "2021-07-06",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2021-07-06",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    },
    {
      "acted_at": "2021-07-07",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    },
    {
      "acted_at": "2021-07-15",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Subcommittee Consideration and Mark-up Session Held.",
      "type": "action"
    },
    {
      "acted_at": "2021-07-15",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .",
      "type": "action"
    },
    {
      "acted_at": "2021-07-21",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Committee Consideration and Mark-up Session Held.",
      "type": "action"
    },
    {
      "acted_at": "2021-07-21",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REPORTED",
      "text": "Ordered to be Reported (Amended) by Voice Vote.",
      "type": "ordered-reported"
    },
    {
      "acted_at": "2021-10-19",
      "action_code": "H12200",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-151.",
      "type": "action"
    },
    {
      "acted_at": "2021-10-19",
      "action_code": "H12410",
      "calendar": "Union",
      "number": "111",
      "references": [],
      "text": "Placed on the Union Calendar, Calendar No. 111.",
      "type": "calendar",
      "under": null
    },
    {
      "acted_at": "2021-10-19T16:01:03-04:00",
      "action_code": "H30300",
      "references": [],
      "text": "Mr. Pallone moved to suspend the rules and pass the bill, as amended.",
      "type": "action"
    },
    {
      "acted_at": "2021-10-19T16:01:18-04:00",
      "action_code": "H30000",
      "references": [
        {
          "reference": "CR H5645-5647",
          "type": "consideration"
        }
      ],
      "text": "Considered under suspension of the rules.",
      "type": "action"
    },
    {
      "acted_at": "2021-10-19T16:01:19-04:00",
      "action_code": "H8D000",
      "references": [],
      "text": "DEBATE - The House proceeded with forty minutes of debate on H.R. 4369.",
      "type": "action"
    },
    {
      "acted_at": "2021-10-19T16:08:05-04:00",
      "action_code": "H37220",
      "references": [],
      "text": "At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.",
      "type": "action"
    },
    {
      "acted_at": "2021-10-19T19:19:41-04:00",
      "action_code": "H30000",
      "references": [
        {
          "reference": "CR H5662-5663",
          "type": "consideration"
        }
      ],
      "text": "Considered as unfinished business.",
      "type": "action"
    },
    {
      "acted_at": "2021-10-19T19:36:14-04:00",
      "action_code": "H37300",
      "how": "roll",
      "references": [
        {
          "reference": "CR H5645-5647",
          "type": "text"
        }
      ],
      "result": "pass",
      "roll": "318",
      "status": "PASS_OVER:HOUSE",
      "suspension": true,
      "text": "On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 368 - 56 (Roll no. 318).",
      "type": "vote",
      "vote_type": "vote",
      "where": "h"
    },
    {
      "acted_at": "2021-10-19T19:36:15-04:00",
      "action_code": "H38310",
      "references": [],
      "text": "Motion to reconsider laid on the table Agreed to without objection.",
      "type": "action"
    },
    {
      "acted_at": "2021-10-19T19:36:22-04:00",
      "action_code": "H38800",
      "references": [],
      "text": "The title of the measure was amended. Agreed to without objection.",
      "type": "action"
    },
    {
      "acted_at": "2021-10-20",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "text": "Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr4369-117",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [
    "H. Rept. 117-151"
  ],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    },
    {
      "activity": [
        "reporting",
        "markup",
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "reporting",
        "markup",
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "G000558",
      "district": "2",
      "name": "Guthrie, Brett",
      "original_cosponsor": true,
      "sponsored_at": "2021-07-06",
      "state": "KY",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": true,
    "active_at": "2021-07-15",
    "awaiting_signature": false,
    "enacted": false,
    "house_passage_result": "pass",
    "house_passage_result_at": "2021-10-19T19:36:14-04:00",
    "vetoed": false
  },
  "introduced_at": "2021-07-06",
  "number": "4369",
  "official_title": "To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "s2589-117",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021",
  "sponsor": {
    "bioguide_id": "P000034",
    "district": "6",
    "name": "Pallone, Frank, Jr.",
    "state": "NJ",
    "title": "Rep.",
    "type": "person"
  },
  "status": "PASS_OVER:HOUSE",
  "status_at": "2021-10-19T19:36:14-04:00",
  "subjects": [
    "Advanced technology and technological innovations",
    "Congressional oversight",
    "Department of Health and Human Services",
    "Drug safety, medical device, and laboratory regulation",
    "Food and Drug Administration (FDA)",
    "Government information and archives",
    "Health",
    "Health programs administration and funding",
    "Health technology, devices, supplies",
    "Higher education",
    "Manufacturing",
    "Prescription drugs",
    "Product development and innovation",
    "Research administration and funding",
    "Research and development"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Passed House",
    "asOf": "2021-10-19",
    "date": "2021-12-01T11:51:18Z",
    "text": "National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021 \n\nThis bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education (or consortia of such institutions) as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on advanced and continuous pharmaceutical manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)"
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021",
      "type": "display"
    },
    {
      "as": "reported to house",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021",
      "type": "short"
    },
    {
      "as": "passed house",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021",
      "type": "short"
    },
    {
      "as": "passed house",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021",
      "type": "short"
    },
    {
      "as": "amended by house",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on advanced and continuous pharmaceutical manufacturing as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing, and for other purposes.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2023-03-08T20:26:20Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/hr/BILLSTATUS-117hr4369.xml"
}